Gildess 1 recalls
The FDA has published 1 recall involving Gildess 1 since 2016. The latest was reported on 9 Nov 2016. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2016
Last 12 months0reported
Class I00% of total
Ongoing0latest 9 Nov 2016
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 1 100%
Why gildess 1 is recalled
Companies
By year
All gildess 1 recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Gildess 1/20 (norethindrone acetate, 1 mg recalled by Par Pharmaceutical | Par Pharmaceutical | Potency & Assay | Nationwide |
Should you stop taking Gildess 1?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.